About Cell Medica
Cell Medica is a clinical cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease. The Company’s lead cell therapy targets the prevention of infections in immunosuppressed patients following allogeneic bone marrow transplant. Cell Medica focuses on the commercialisation of cell therapies which have demonstrated clear evidence of safety and efficacy based on Phase I/II clinical trials.
The Company began its research operations in February 2007. With the guidance of its Scientific Advisory Team and funding provided by the Wellcome Trust and Imperial Innovations, the Company has progressed in a short period to the clinical phase of development with respect to its lead cell therapy applications.
- Industry : Pharma
